Detalhe da pesquisa
1.
Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials.
Ann Oncol
; 33(2): 119-122, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839015
2.
Testing for COVID-19 in lung cancer patients.
Ann Oncol
; 31(7): 832-834, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32278879
3.
Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).
ESMO Open
; 8(2): 101192, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965261
4.
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers.
Clin Lung Cancer
; 24(1): e19-e26, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372676
5.
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.
ESMO Open
; 7(1): 100355, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922299
6.
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges.
J Immunother Cancer
; 7(1): 205, 2019 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383005
7.
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes.
Eur J Cancer
; 101: 191-200, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30077124